The first “three places listed” biotechnology leader is coming!
Next Thursday (December 2), Baiji Shenzhou, a leading innovative drug enterprise, will apply for new shares. As the largest heavyweight stock with a high position in U.S. stocks, the IPO price of Baiji Shenzhou’s science and Innovation Board may exceed 100 yuan.
It is worth noting that the recent performance of new shares has warmed up and the new Legion has gradually returned. The five registered new shares listed this week doubled on the first day of listing, of which the single signing profit of Haili wind power exceeded 50000 yuan.
performance of new shares recovered
won 50000 yuan in the first signing
Five registered new shares were listed this week, with an average increase of 205.58% on the first day of listing, and Admiralty shares increased by nearly 300%.
Among the five registered new shares, Haili wind power has the highest new income, and the profit of winning the first signing reached 53200 yuan; Followed by Yunlu shares, the first signing can earn 42500 yuan. The lowest new income is Zhengqiang shares, and the profit of the first signing also reached 17300 yuan.
With the recent pick-up in the performance of new shares, the new Legion gradually returned to the market. The number of new share subscription households rose by nearly 500000 compared with the beginning of the month, and the abandonment rate also returned to a relatively normal level.
The data show that the average number of effective online subscription households on the gem rebounded to 13.68 million this week, with an average of 13.21 million in the first two weeks of November; This week, the average number of effective online subscription households on the science and Innovation Board rebounded to 5.54 million, with an average of 5.07 million in the first two weeks of November.
In early November, affected by the continuous issuance of new shares under the registration system, the number of new share subscription households once plummeted by one million, and even a large number of winners abandoned their purchases.
the first biotechnology leader to be listed in three places
Next Thursday, Baiji Shenzhou, a leading innovative drug enterprise, will apply for new shares on the science and innovation board. This also means that Baiji China will soon become the first biomedical company listed on Nasdaq, HKEx and Shanghai Stock Exchange.
Baiji Shenzhou plans to issue 115 million shares to the public this time. Before the exercise of the over allotment right, the issuance volume accounts for 8.62% of the total number of shares issued as of October 31 this year and the sum of the number of shares to be issued this time. If the over allotment right is exercised in full, the total number of shares issued will be expanded to 132 million shares.
Baiji Shenzhou plans to raise 20 billion yuan for the listing of the science and innovation board. Based on this calculation, the issuing price of Baiji Shenzhou may exceed 100 yuan, and its total market value may exceed 200 billion yuan.
Founded in 2010, Baiji Shenzhou was listed on NASDAQ in 2016 and Hong Kong stocks in 2018. The latest share price of Baiji Shenzhou Hong Kong stock is HK $210.8, with a total market value of HK $255.9 billion (about 209.8 billion yuan); The latest share price of Baiji Shenzhou US shares was US $347.69, with a total market value of US $32.5 billion (about 207.8 billion yuan).
Baiji Shenzhou introduced the “green shoe” mechanism in this offering, which will help to stabilize its initial stock price performance. Up to now, Baiji Shenzhou is still in a state of loss. It is worth mentioning that in the U.S. stock positions in the third quarter of Hillhouse, Baiji Shenzhou still ranks first among the top ten heavy positions.
Wind data show that since this year, there have been 10 new shares with an issue price of more than 100 yuan, of which 4 have a single signature profit of more than 100000 yuan, while Liaoning Chengda Biotechnology Co.Ltd(688739) listed at the end of October broke on the first day of listing.
list of new share subscription information next week
According to the arrangement of new share issuance, 8 new shares will be applied for in Shanghai and Shenzhen next week, including 4 on the science and innovation board, 3 on the gem and 1 on the main board of Shanghai stock market.
Zeyu Intelligence: mainly engaged in power information business, including power consulting and design, system integration, engineering construction and operation and maintenance
Tongling shares: is mainly engaged in the R & D, production and sales of Cecep Solar Energy Co.Ltd(000591) photovoltaic module junction box and other accessories
Jialian Technology: mainly engaged in the R & D, production and sales of high-end plastic products and fully biodegradable products
Dongxin shares: is mainly engaged in the R & D, design and sales of small and medium-sized general-purpose memory chips
Dizhe medicine: is mainly engaged in the mining of new targets and the verification of action mechanism. With the help of the company’s own transformation scientific research ability and technical platform, it explores the relationship between the clinical characteristics of diseases and possible abnormal driving genes and protein structures
Mengtian home: mainly engaged in the design, R & D, production and sales of customized wooden furniture such as wooden doors, wallboards and cabinets
Baiji Shenzhou: mainly engaged in research, development, production and commercialization of innovative drugs
Jiahe Meikang: mainly engaged in the R & D and industrialization of medical information software
(China Securities Journal)
